Baxter ROE 2006-2018 | BAX

Current and historical return on equity (ROE) values for Baxter (BAX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Baxter ROE for the three months ending September 30, 2018 was 17.67%.
Baxter ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $1.21B $9.11B 13.32%
2018-06-30 $0.91B $8.87B 9.98%
2018-03-31 $0.83B $9.09B 9.06%
2017-12-31 $0.72B $9.12B 7.88%
2017-09-30 $1.03B $9.46B 11.59%
2017-06-30 $0.91B $9.17B 10.46%
2017-03-31 $1.86B $8.68B 21.76%
2016-12-31 $4.97B $8.28B 57.61%
2016-09-30 $4.93B $8.66B 56.21%
2016-06-30 $4.80B $8.51B 56.05%
2016-03-31 $3.92B $9.02B 46.43%
2015-12-31 $0.97B $8.87B 12.09%
2015-09-30 $1.72B $7.85B 21.92%
2015-06-30 $2.18B $8.02B 27.38%
2015-03-31 $2.37B $7.29B 29.13%
2014-12-31 $2.50B $8.16B 29.41%
2014-09-30 $1.87B $8.43B 21.81%
2014-06-30 $1.95B $8.69B 23.16%
2014-03-31 $2.02B $8.69B 25.01%
2013-12-31 $2.01B $8.49B 26.35%
2013-09-30 $2.18B $7.75B 30.03%
2013-06-30 $2.22B $7.32B 31.16%
2013-03-31 $2.29B $7.00B 32.97%
2012-12-31 $2.33B $6.98B 33.54%
2012-09-30 $2.30B $7.19B 33.27%
2012-06-30 $2.29B $6.61B 33.17%
2012-03-31 $2.24B $6.96B 31.77%
2011-12-31 $2.22B $6.83B 31.51%
2011-09-30 $2.18B $7.19B 30.98%
2011-06-30 $2.13B $7.24B 30.72%
2011-03-31 $2.05B $6.97B 30.80%
2010-12-31 $1.42B $6.80B 21.55%
2010-09-30 $1.57B $6.76B 23.27%
2010-06-30 $1.57B $6.13B 22.87%
2010-03-31 $1.63B $6.66B 23.09%
2009-12-31 $2.21B $7.42B 31.88%
2009-09-30 $2.20B $7.31B 33.20%
2009-06-30 $2.14B $6.77B 32.63%
2009-03-31 $2.10B $6.16B 31.44%
2008-12-31 $2.01B $6.29B 29.22%
2008-09-30 $1.92B $7.06B 27.29%
2008-06-30 $1.85B $7.22B 26.93%
2008-03-31 $1.73B $7.00B 25.78%
2007-12-31 $1.71B $6.92B 25.77%
2007-09-30 $1.66B $6.29B 25.70%
2007-06-30 $1.64B $6.69B 25.33%
2007-03-31 $1.52B $6.60B 24.21%
2006-12-31 $1.40B $6.27B 23.07%
2006-09-30 $1.26B $6.34B 22.60%
2006-06-30 $1.00B $5.87B 19.70%
2006-03-31 $1.01B $5.75B 21.73%
2005-12-31 $0.96B $4.30B 22.63%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $35.627B $10.561B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $128.261B 19.18
Abbott Laboratories (ABT) United States $126.772B 25.69
Stryker (SYK) United States $64.682B 24.38
Boston Scientific (BSX) United States $51.173B 25.86
Zimmer Biomet Holdings (ZBH) United States $22.919B 14.86
Smith & Nephew SNATS (SNN) United Kingdom $16.781B 0.00
ResMed (RMD) United States $16.435B 31.34
Perrigo (PRGO) Ireland $7.949B 12.06
Bio-Rad Laboratories (BIO) United States $7.499B 47.95
Canopy Growth (CGC) Canada $7.155B 0.00
Hill-Rom Holdings (HRC) United States $6.373B 19.94
Aurora Cannabis (ACB) Canada $5.690B 30.05
Haemonetics (HAE) United States $5.320B 46.79
Insulet (PODD) United States $4.792B 0.00
ICU Medical (ICUI) United States $4.683B 26.09
Hutchison China MediTech (HCM) China $4.520B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.645B 0.00
Neogen (NEOG) United States $3.295B 49.90
Agios Pharmaceuticals (AGIO) United States $3.098B 0.00
NuVasive (NUVA) United States $2.887B 26.87
National Vision Holdings (EYE) United States $2.368B 45.81
Quidel (QDEL) United States $1.995B 26.01
NxStage Medical (NXTM) United States $1.905B 0.00
Phibro Animal Health (PAHC) United States $1.329B 18.81
Aphria (APHA) $1.306B 0.00
AtriCure (ATRC) United States $1.170B 0.00
Cardiovascular Systems (CSII) United States $0.999B 1437.00
VAREX IMAGING (VREX) United States $0.910B 18.23
PetIQ (PETQ) United States $0.848B 21.99
Meridian Bioscience (VIVO) United States $0.771B 24.58
Cerus (CERS) United States $0.769B 0.00
Surmodics (SRDX) United States $0.765B 116.47
OraSure Technologies (OSUR) United States $0.727B 40.93
Lantheus Holdings (LNTH) United States $0.664B 20.56
Omeros (OMER) United States $0.656B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.643B 20.63
MacroGenics (MGNX) United States $0.624B 0.00
NanoString Technologies (NSTG) United States $0.526B 0.00
LeMaitre Vascular (LMAT) United States $0.514B 25.24
Quanterix (QTRX) United States $0.442B 0.00
Owens & Minor (OMI) United States $0.421B 4.76
TG Therapeutics (TGTX) United States $0.414B 0.00
Insys Therapeutics (INSY) United States $0.366B 0.00
Evolus (EOLS) United States $0.336B 0.00
Utah Medical Products (UTMD) United States $0.324B 20.93
VAPOTHERM INC (VAPO) United States $0.301B 0.00
Cytosorbents (CTSO) United States $0.277B 0.00
Surface Oncology (SURF) United States $0.236B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.235B 0.00
Bovie Medical (BVX) United States $0.231B 0.00
BioLife Solutions (BLFS) United States $0.205B 276.75
Rockwell Medical (RMTI) United States $0.172B 0.00
Chimerix (CMRX) United States $0.170B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.139B 0.00
Fonar (FONR) United States $0.135B 6.78
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.080B 16.84
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.33
CAS Medical Systems (CASM) United States $0.050B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Neurotrope (NTRP) United States $0.035B 0.00
Myomo (MYO) United States $0.023B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00